Induction therapy with consensus interferon in the treatment of patients with chronic hepatitis C.

被引：0

作者：

Kwo, PY ^{[1
]}

Fields, S ^{[1
]}

Chalasani, N ^{[1
]}

Cho, W ^{[1
]}

Crabb, DW ^{[1
]}

Cummings, OW ^{[1
]}

Imperiale, TF ^{[1
]}

Lumeng, L ^{[1
]}

McGill, JM ^{[1
]}

Ness, RM ^{[1
]}

Pintozzi, R ^{[1
]}

Jones, B ^{[1
]}

Lansford, C ^{[1
]}

Maier, J ^{[1
]}

Isenberg, M ^{[1
]}

Mark, D ^{[1
]}

Bennet, C ^{[1
]}

Noar, M ^{[1
]}

McCone, J ^{[1
]}

Chasen, R ^{[1
]}

Geissinger, B ^{[1
]}

Goldstein, M ^{[1
]}

Thuluvath, P ^{[1
]}

机构：

[1] Indiana Univ, Indianapolis, IN 46204 USA

来源：

GASTROENTEROLOGY | 2000年 / 118卷 / 04期

关键词：

D O I：

10.1016/S0016-5085(00)81738-2

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

6617

引用

页码：A1460 / A1460

页数：1

共 50 条

[21] Successful retreatment of peginterferon nonresponder patients with chronic hepatitis C with high dose consensus interferon induction therapy
Kaiser, S
Hass, H
Gregor, M
GASTROENTEROLOGY, 2004, 126 (04) : A668 - A668
[22] Successful Retreatment of peginterferon nonresponder patients with chronic hepatitis C with high dose consensus interferon induction therapy
Kaiser, S
Hass, H
Gregor, M
GASTROENTEROLOGY, 2003, 124 (04) : A700 - A700
[23] Consensus interferon for earlier non-responder or relapser patients with chronic hepatitis C.
Karasu, Z
Gurakar, A
Jazzar, A
Emmett, C
Hulagu, S
Wright, H
HEPATOLOGY, 1999, 30 (04) : 629A - 629A
[24] Cytokine production during interferon treatment in patients with chronic hepatitis C.
Bozkaya, H
Bozdayi, AM
Arslan, N
Cetinkaya, H
Akdogan, M
Sentürk, H
Akkiz, H
Yurdaydin, C
Karayalçin, S
Uzunalimoglu, Ö
HEPATOLOGY, 1998, 28 (04) : 361A - 361A
[25] Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-α therapy
Böcher, WO
Schuchmann, M
Link, R
Hillenbrand, H
Rahman, F
Sprinzl, M
Mudter, J
Löhr, HF
Galle, PR
LIVER INTERNATIONAL, 2006, 26 (03) : 319 - 325
[26] Histological response of interferon therapy in chronic hepatitis C.
Segawa, T
Moriyama, M
Shibahara, N
Kaneko, M
Suzuki, K
Tanaka, N
Okubo, H
Ishizuka, H
Arakawa, Y
Sugitani, M
Suzuki, K
Uchida, T
Shikata, T
GASTROENTEROLOGY, 1997, 112 (04) : A1378 - A1378
[27] Breakthrough and interferon dose in the therapy of chronic hepatitis C.
Bellati, G
Roffi, L
Colloredo, G
DAcquino, M
Ricci, A
Redaelli, A
Tempini, S
Bellobuono, A
Bonino, F
Ideo, G
HEPATOLOGY, 1996, 23 (01) : P97 - P97
[28] Treatment of chronic hepatitis B/C coinfected patients with consensus interferon/ribavirin/lamivudine triple therapy
Kaiser, S
Hass, HG
Gregor, M
JOURNAL OF HEPATOLOGY, 2003, 38 : 148 - 148
[29] The role of triple therapy (interferon, ribavirin and amantadine) in the treatment of chronic hepatitis C.
Vlodov, J
Charania, M
Jose, RM
Iswara, K
Lapin, S
Terebelo, S
Bernstein, M
Tenner, S
HEPATOLOGY, 2000, 32 (04) : 565A - 565A
[30] Glucose intolerance in poor response to interferon therapy in the patients with chronic hepatitis C.
Kikuchi, I
HEPATOLOGY, 2001, 34 (04) : 602A - 602A

← 1 2 3 4 5 →